Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Dauntless Investment Group, LLC AZTR Azitra, Inc. 13G 9.6% 5mo
Avenue Venture Opportunities Fund II, L.P. CALC CalciMedica, Inc. 13G/A 4.99% 5mo
Helena Global Investment Opportunities 1 Ltd. DEVSF DevvStream Legacy Corp. 13G/A 0% 5mo
Takeover Time 2026 LLC ADTX Aditxt, Inc. 13D/A 0% 5mo
STEEL PARTNERS HOLDINGS L.P. SPRU Spruce Power Holding Corp 13D/A 18.7% 5mo
Peter J Abrahamson UFI Unifi Inc 13G 5.2% 5mo
BW Group Limited NVGS Navigator Holdings Ltd. 13D/A 9.87% 5mo
Stachowiak Raymond C AMS American Shared Hospital Services 13D/A 33% 5mo
Michael Liu SNGX Soligenix, Inc. 13G 5.7% 5mo
Sculptor Capital LP WLCO Wilco 63 Corp 13G 5.19% 5mo
Baselake Partners, LP PASG Passage BIO, Inc. 13G 7.3% 5mo
JANE STREET GROUP, LLC LESLQ Leslie's, Inc. 13G 5.1% 5mo
Philotimo Fund, LP ALLT Allot Ltd. 13D 4.7% 5mo
GLAZER CAPITAL, LLC ALOT AstroNova, Inc. 13G 5.81% 5mo
PERCEPTIVE ADVISORS LLC KARD Kardigan, Inc. 13D 8.9% 5mo
Helix Partners Management LP OPI Office Properties Income Trust 13D 25.3% 5mo
Les Filles, LLC SRXH SRX Global Inc. 13G 6.2% 5mo
Millennium Management LLC HQ Horizon Quantum Holdings Ltd. 13G 0.1% 5mo
MILLENNIUM MANAGEMENT LLC XNDU Xanadu Quantum Technologies Ltd 13G 0.2% 5mo
EcoR1 Capital, LLC FULC Fulcrum Therapeutics, Inc. 13G 9% 5mo
Mountain Crest Holdings 6 LLC MCAH Mountain Crest Acquisition 6 Corp. 13G 29.98% 5mo
GreenTech Investment Alliance Ltd. RYDE Ryde Group Ltd 13G 6.62% 5mo
HOROWITZ RICHARD M TRT Trio-Tech International 13D/A 8.6% 5mo
Corley Thomas John GDC GD Culture Group Ltd 13G/A 0.9% 5mo
Tai Wey Ann ADTX Aditxt, Inc. 13G/A 0% 5mo
Ephraim G Fields HSCS HeartSciences Inc. 13G 8.1% 5mo
YZILabs Management Ltd. BNC BNB Standard Corp 13D/A 5.07% 5mo
Apollo Principal Holdings A GP, Ltd HGV Hilton Grand Vacations Inc. 13D/A 15.9% 5mo
Imperial Petroleum Inc. CISS C3is Inc. 13D/A 82.9% 5mo
RA CAPITAL MANAGEMENT, L.P. SLDB Solid Biosciences Inc. 13D/A 11.9% 5mo
James H. Dahl AXR Amrep Corp. 13D/A 18.8% 5mo
Ni Andy ADTX Aditxt, Inc. 13G/A 0% 5mo
GLOBAL VALUE INVESTMENT CORP. LOOP Loop Industries, Inc. 13D/A 6.89% 5mo
John C. Malone LILA Liberty Latin America Ltd. 13D/A 12.6% 5mo
MCB PR Capital LLC WSR Whitestone REIT 13D/A 0% 5mo
ORBIMED ADVISORS LLC ELVN Enliven Therapeutics, Inc. 13D/A 9.5% 5mo
Cevian Capital II GP LTD SNN Smith & Nephew PLC 13D/A 13.09% 5mo
Flawless Management Inc. IMPP Imperial Petroleum Inc./Marshall Islands 13D/A 15.7% 5mo
JANE STREET GROUP, LLC ASTI Ascent Solar Technologies, Inc. 13G 5.3% 5mo
Altitude V Holdings, LLC AVAV AeroVironment Inc 13D/A 13.5% 5mo
Coastlands Capital LP AZR Azora Therapeutics, Inc. (DE) 13G 9.98% 5mo
JANE STREET GROUP, LLC GLXY Galaxy Digital Inc. 13G 5.1% 5mo
S.H.N. Financial Investments Ltd. CIIT Tianci International, Inc. 13G 9.99% 5mo
Lawrence M. Blatt, Ph.D. ALGS Aligos Therapeutics, Inc. 13D 5.6% 5mo
FARALLON CAPITAL MANAGEMENT LLC CNTA Centessa Pharmaceuticals plc 13D 6.1% 5mo
Paradigm Biocapital Advisors LP MBX MBX Biosciences, Inc. 13G 5.2% 5mo
Salva Francisco D. AZTR Azitra, Inc. 13D 9.99% 5mo
MILLENNIUM MANAGEMENT LLC DXC DXC Technology Co 13G 5.7% 5mo
Hester Jonathan Edward ADTX Aditxt, Inc. 13G/A 0% 5mo
Moshe Mizrahy INMD InMode Ltd. 13D/A 7.9% 5mo